Nicki Vasquez Sutro Biopharma, Inc. (STRO) insider trading activity

Nicki Vasquez is CHIEF PORT. STRAT & ALNCE OFCR of SUTRO BIOPHARMA, INC.. Currently has a direct ownership of 14,279 shares of STRO, which is worth approximately $46,406. The most recent transaction as insider was on Jan 29, 2024, when has been sold 1,024 shares (Common Stock) at a price of $4.99 per share, resulting in proceeds of $5,109. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.3K

0% 3M change

42.86% 12M change

Total Value Held $46,406

Nicki Vasquez Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 29 2024	SELL Payment of exercise price or tax liability	$5,109 $4.99 p/Share	1,024 Reduced 6.69%	14,279 Common Stock
Jan 29 2024	SELL Open market or private sale	$60,925 $5.0 p/Share	12,185 Reduced 48.76%	12,803 Common Stock
Jan 29 2024	BUY Exercise of conversion of derivative security	-	2,500 Added 14.04%	15,303 Common Stock
Jul 12 2023	SELL Payment of exercise price or tax liability	$5,278 $4.7 p/Share	1,123 Reduced 4.3%	24,988 Common Stock
Jul 12 2023	BUY Exercise of conversion of derivative security	-	3,250 Added 11.07%	26,111 Common Stock
Mar 03 2023	SELL Payment of exercise price or tax liability	$28,892 $5.79 p/Share	4,990 Reduced 17.92%	22,861 Common Stock
Mar 03 2023	BUY Exercise of conversion of derivative security	-	12,250 Added 30.55%	27,851 Common Stock
Jan 27 2023	SELL Payment of exercise price or tax liability	$7,642 $7.5 p/Share	1,019 Reduced 6.13%	15,601 Common Stock
Jan 27 2023	BUY Exercise of conversion of derivative security	-	2,500 Added 13.08%	16,620 Common Stock
Jul 12 2022	SELL Payment of exercise price or tax liability	$6,828 $6.08 p/Share	1,123 Reduced 7.37%	14,120 Common Stock
Jul 12 2022	BUY Exercise of conversion of derivative security	-	3,250 Added 17.57%	15,243 Common Stock
Mar 05 2022	SELL Payment of exercise price or tax liability	$18,407 $8.17 p/Share	2,253 Reduced 15.81%	11,993 Common Stock
Mar 05 2022	BUY Exercise of conversion of derivative security	-	5,500 Added 27.85%	14,246 Common Stock
Jan 29 2022	SELL Payment of exercise price or tax liability	$10,639 $10.39 p/Share	1,024 Reduced 10.48%	8,746 Common Stock
Jan 29 2022	BUY Exercise of conversion of derivative security	-	2,500 Added 20.37%	9,770 Common Stock
Sep 28 2021	SELL Open market or private sale	$72,730 $18.62 p/Share	3,906 Reduced 34.95%	7,270 Common Stock
Sep 24 2021	SELL Payment of exercise price or tax liability	$39,671 $19.23 p/Share	2,063 Reduced 15.58%	11,176 Common Stock
Sep 24 2021	BUY Exercise of conversion of derivative security	-	5,969 Added 31.08%	13,239 Common Stock

Nicki Vasquez

CHIEF PORT. STRAT & ALNCE OFCR

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STRO shares.

Notify only if

Value

Insider Trading

Get notified when an Sutro Biopharma, Inc. insider buys or sells STRO shares.

Notify only if

Operation

Value

Type

News

Receive news related to SUTRO BIOPHARMA, INC.

Track Activities on STRO

Account